ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 1 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,251 | +4.2% | 95,297 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $1,200 | -3.5% | 95,297 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $1,243 | -75.4% | 95,297 | -66.8% | 0.01% | -80.0% |
| Q4 2022 | $5,056 | -99.9% | 286,845 | -33.4% | 0.02% | -30.6% |
| Q3 2022 | $6,549,000 | +5594.8% | 430,681 | +5484.6% | 0.04% | +3500.0% |
| Q2 2022 | $115,000 | -95.8% | 7,712 | -96.3% | 0.00% | -90.9% |
| Q3 2021 | $2,763,000 | -66.8% | 206,708 | -54.1% | 0.01% | -64.5% |
| Q2 2021 | $8,333,000 | +33.3% | 450,224 | +8.1% | 0.03% | +29.2% |
| Q1 2021 | $6,253,000 | +850.3% | 416,428 | +815.0% | 0.02% | +700.0% |
| Q4 2020 | $658,000 | +24.9% | 45,510 | -41.6% | 0.00% | +50.0% |
| Q2 2020 | $527,000 | -57.2% | 77,906 | -35.4% | 0.00% | -66.7% |
| Q4 2016 | $1,232,000 | -94.5% | 120,625 | -92.9% | 0.01% | -94.6% |
| Q3 2016 | $22,355,000 | +105.6% | 1,697,615 | +98.3% | 0.11% | +98.2% |
| Q2 2016 | $10,873,000 | +2753.8% | 856,244 | +2872.6% | 0.06% | +2700.0% |
| Q1 2016 | $381,000 | – | 28,805 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENHILL ADVISORS LLC | 10,507,149 | $138,799,000 | 8.42% |
| Tamarack Advisers, LP | 1,650,000 | $21,797,000 | 7.63% |
| Blue Harbour Group | 10,759,695 | $142,136,000 | 4.78% |
| BROADVIEW ADVISORS LLC | 1,095,800 | $14,476,000 | 2.08% |
| Rovida Advisors Inc. | 752,400 | $9,939,000 | 2.04% |
| Adirondack Research & Management Inc. | 361,259 | $4,772,000 | 1.73% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,104,400 | $14,589,000 | 1.70% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 14,401,161 | $190,239,000 | 1.62% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 5,077,304 | $67,071,000 | 1.30% |
| Iguana Healthcare Management, LLC | 250,000 | $3,303,000 | 1.21% |